These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29123575)

  • 1. Systemic sclerosis and the gastrointestinal tract.
    Walecka I
    Prz Gastroenterol; 2017; 12(3):163-168. PubMed ID: 29123575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
    Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA;
    PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating peroxisome proliferator-activated receptor γ is elevated in systemic sclerosis.
    Żółkiewicz J; Stochmal A; Zaremba M; Rudnicka L; Czuwara J
    Postepy Dermatol Alergol; 2020 Dec; 37(6):921-926. PubMed ID: 33603610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.
    Wirz EG; Jaeger VK; Allanore Y; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Tikly M; Vettori S; Balbir Gurman A; Damjanov N; Müller-Ladner U; Distler J; Li M; Häusermann P; Walker UA;
    Ann Rheum Dis; 2016 Jul; 75(7):1285-92. PubMed ID: 26232495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to diagnosis in systemic sclerosis: is sex a factor?
    Hudson M; Thombs B; Baron M;
    Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic sclerosis].
    Legendre P; Mouthon L
    Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic sclerosis].
    Kleinert S; Tony HP; Kneitz C
    Internist (Berl); 2006 Oct; 47(10):1051-61; quiz 1062. PubMed ID: 16972070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets.
    Mahler M; Hudson M; Bentow C; Roup F; Beretta L; Pilar Simeón C; Guillén-Del-Castillo A; Casas S; Fritzler MJ
    Autoimmun Rev; 2020 Aug; 19(8):102583. PubMed ID: 32553611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.
    Young A; Namas R; Dodge C; Khanna D
    Curr Treatm Opt Rheumatol; 2016 Sep; 2(3):252-269. PubMed ID: 28018840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
    Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
    Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.
    Kumar S; Singh J; Rattan S; DiMarino AJ; Cohen S; Jimenez SA
    Aliment Pharmacol Ther; 2017 Apr; 45(7):883-898. PubMed ID: 28185291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mimetics of systemic sclerosis].
    Jendrek ST; Kahle B; Riemekasten G
    Z Rheumatol; 2019 Feb; 78(1):14-23. PubMed ID: 30255410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical approach to scleroderma.
    White B
    Semin Cutan Med Surg; 1998 Sep; 17(3):213-8. PubMed ID: 9759679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression.
    Cavazzana I; Ceribelli A; Airo' P; Zingarelli S; Tincani A; Franceschini F
    Autoimmun Rev; 2009 Jun; 8(7):580-4. PubMed ID: 19393210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.